Event | 27 February – 1 March, 2023
Society for Laboratory Automation and Screening International Conference and Exhibition 2023
Join us in San Diego.
Come and join us at SLAS 2023 to learn how Polar can help you navigate your biopharma lifecycle by securely managing drug progression in contexts of workflow, intergration and insight.
Read “Accelerating Time-to-Insight Across the BioPharma Lifecycle” in BioPharm International, written by IDBS’ Pietro Forgione, Vice President of Strategy to learn how a strong digital backbone is foundational in driving innovation.
Over time, greater insights driven by timely access to data also lead to better study design which increases right-first-time development efforts and reduces the number of experiments needed.
Learn more about Polar.
We look forward to connecting with you at SLAS!
About SLAS2023 International Conference and Exhibition: This year’s scientific program will bring more than 150 scientific talks spanning nine educational tracks within life sciences, technology and laboratory automation. Sessions will build off of the innovative, life-changing and sometimes surprising discoveries from over the last year.
Meet the team
Dave Watrous, Commercial Director for BioPharma Lifecycle Management
Dave is the Commercial Director for BioPharma Lifecycle Management at IDBS, bringing over 20 years of experience to the team.
Before IDBS, his career spans roles from the bench to leading operational and commercial teams in the CDMO, CRO and Life Science tools markets. This includes a role as Global Account Executive at Cytiva, where he supported the overall relationships with both Merck/MSD and Takeda. Beyond his experience with Cytiva, he was a Senior Business Development Director at Covance.
Dave holds a BSc in Biochemistry and in Genetics, Cell Biology, and Development for the University of Minnesota and a MSc in Cancer Biology from the University of Wisconsin – Madison.
Fi Rich, Global Strategic Account Manager
Fi has been with IDBS for two years and is responsible for supporting BioPharma, CRO and CDMO customers in reaching their digital and data strategy goals.
Prior to IDBS, Fi spent over 20 years on the commercial side of Pharmaceuticals, MedTech and System Integration with several companies including J&J, Baxter and Olympus Medical. Gaining diverse experience from marketing and professional education to P&L responsibilities and mergers and acquisitions, Fi can help clients navigate various business challenges to help achieve their program improvements through optimized change management.
She has a degree in Applied Sciences from Nottingham Trent University.